Novartis Ag (NVS) Net Income (2009 - 2026)
Novartis Ag's Net Income was $3.26 billion in Q2 2026, down 19.1% from $4.02 billion a year earlier but up 3.2% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Net Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novartis Ag's Net Income was $12.75 billion through Jun 30, 2026, down 6.5% year-over-year; for FY2025, it was $13.97 billion, up 17.0% from FY2024.
- Net Income has now increased for three consecutive years, with a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- In earlier years, Net Income was $11.94 billion in FY2024 (+39.3%), $8.57 billion in FY2023 (+41.7%), $6.05 billion in FY2022 (-73.6%) and $22.91 billion in FY2021 (+183.8%).
- Quarterly Net Income has moved between $1.32 billion (Q4 2022) and $16.31 billion (Q4 2021) over five years.
- Compared with a year earlier, Net Income has declined for three straight quarters, with growth averaging 19.1% over the last eight quarters.
- The best year-over-year quarter for Net Income over five years was Q4 2021 (growth of 676.8%); the worst was Q4 2022 (a decline of 91.9%).
- Per Business Quant data, NVS's Net Income in the three quarters before Q2 2026 was $3.16 billion (Q1 2026), $2.4 billion (Q4 2025) and $3.93 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vertex Pharmaceuticals | 141.76 Bn | 113.76 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.16 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.93 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Dec 31, 2023 | 2.64 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Jun 30, 2023 | 2.27 Bn |
| Mar 31, 2023 | 2.15 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |
API Access
Novartis Ag Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();